-
Start Preamble
ACTION:
Notice of registration.
SUMMARY:
The registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as bulk manufacturers of various classes of schedule I and II controlled substances.
End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
The companies listed below applied to be registered as a bulk manufacturers of various classes of scheduled I and II controlled substances. Information on previously published notices is listed below. No comments or objections were submitted for these notices.Start Printed Page 57749
Company FR Docket Published SpecGx LLC 84 FR 26447 June 6, 2019. Sigma Aldrich Research 84 FR 27659 June 13, 2019. The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of these registrants to manufacture the applicable basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each of the company's maintenance of effective controls against diversion by inspecting and testing the company's physical security systems, verifying the company's compliance with state and local laws, and reviewing each company's background and history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the DEA has granted a registration as a bulk manufacturer to the above listed companies.
Start SignatureDated: October 16, 2019.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2019-23500 Filed 10-25-19; 8:45 am]
BILLING CODE 4410-09-P
Document Information
- Published:
- 10/28/2019
- Department:
- Drug Enforcement Administration
- Entry Type:
- Notice
- Action:
- Notice of registration.
- Document Number:
- 2019-23500
- Pages:
- 57748-57749 (2 pages)
- Docket Numbers:
- Docket No. DEA-392
- PDF File:
- 2019-23500.pdf